Vinflunine for the treatment of breast cancer

Cytotoxic chemotherapy: Still the mainstay of clinical practice for all subtypes metastatic breast cancer

(2016) Chris Twelves et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial

(2016) Massimo Cristofanilli et al.   LANCET ONCOLOGY

5P * MICROTUBULE-DEPOLYMERIZING AGENTS USED IN ANTIBODY-DRUG-CONJUGATES INDUCE ANTITUMOR ACTIVITY BY STIMULATION OF DENDRITIC CELLS

(2014) K. Martin et al.   ANNALS OF ONCOLOGY

A phase I clinical and pharmacokinetic study evaluating vinflunine in combination with epirubicin as first-line treatment in metastatic breast cancer

(2014) S. Chan et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Phase II study of intravenous vinflunine after failure of first-line vinorelbine based regimen for advanced breast cancer

(2012) Maria Blasinska-Morawiec et al.   BREAST

A phase 1 study of vinflunine in combination with trastuzumab for the treatment for HER2-positive metastatic breast cancer

(2012) R. Paridaens et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer

(2011) K. Zaman et al.   BREAST CANCER RESEARCH AND TREATMENT

A phase I study of vinflunine in combination with capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes

(2011) M. Campone et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

(2011) Javier Cortes et al.   LANCET

Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

(2011) José Baselga et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Phase II Trial of Vinflunine As Monotherapy or in Combination with Trastuzumab as First-Line Treatment of Metastatic Breast Cancer

(2010) Denise A. Yardley et al.   CANCER INVESTIGATION

A phase I evaluation of the combination of vinflunine and erlotinib in patients with refractory solid tumors

(2010) Hanna K. Sanoff et al.   INVESTIGATIONAL NEW DRUGS

Phase 2 Study of Single-Agent IV Vinflunine as Third-Line Treatment of Metastatic Breast Cancer After Failure of Anthracycline-/Taxane-Based Chemotherapy

(2009) Pierre Fumoleau et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract

(2009) Joaquim Bellmunt et al.   JOURNAL OF CLINICAL ONCOLOGY

Vinflunine: A New Microtubule Inhibitor Agent

(2008) J. Bennouna et al.   CLINICAL CANCER RESEARCH

Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant Therapy

(2008) A. M. Brewster et al.   JNCI-Journal of the National Cancer Institute